Increase in polymorphonuclear myeloid-derived suppressor cells and regulatory T-cells in children with B-cell acute lymphoblastic leukemia.
Asmaa M ZahranAzza ShiblAmal RayanMohamed Alaa Eldeen Hassan MohamedAmira M M OsmanKhaled SaadKhaled Hashim MahmoudAliaa M A GhandourKhalid I ElsayhOmnia El-BadawyPublished in: Scientific reports (2021)
Our study aimed to evaluate the levels of MDSCs and Tregs in pediatric B-cell acute lymphoblastic leukemia (B-ALL), their relation to patients' clinical and laboratory features, and the impact of these cells on the induction response. This study included 31 pediatric B-ALL patients and 27 healthy controls. All patients were treated according to the protocols of the modified St. Jude Children's Research Hospital total therapy study XIIIB for ALL. Levels of MDSCs and Tregs were analyzed using flow cytometry. We observed a reduction in the levels of CD4 + T-cells and an increase in both the polymorphonuclear MDSCs (PMN-MDSCs) and Tregs. The frequencies of PMN-MDSCs and Tregs were directly related to the levels of peripheral and bone marrow blast cells and CD34 + cells. Complete postinduction remission was associated with reduced percentages of PMN-MDSCs and Tregs, with the level of PMN-MDCs in this subpopulation approaching that of healthy controls. PMN-MDSCs and Tregs jointly play a critical role in maintaining an immune-suppressive state suitable for B-ALL tumor progression. Thereby, they could be independent predictors of B-ALL progress, and finely targeting both PMN-MDSCs and Tregs may be a promising approach for the treatment of B-ALL.
Keyphrases
- acute lymphoblastic leukemia
- induced apoptosis
- end stage renal disease
- ejection fraction
- newly diagnosed
- regulatory t cells
- bone marrow
- cell cycle arrest
- prognostic factors
- young adults
- peritoneal dialysis
- rheumatoid arthritis
- stem cells
- immune response
- healthcare
- systemic lupus erythematosus
- signaling pathway
- dendritic cells
- drug delivery
- disease activity
- nk cells